Fighting cancer together on #WorldCancerDay

A group of nurses holding signs for World Cancer Day
Advanced oncology care team at Medical City Dallas Hospital

Graphic that says We are Sarah Cannon and We will Fight Cancer Together

From colorectal, breast and lung to skin, pancreatic and blood, cancer emerges in many ways and can affect anyone at any time. Cancer is the second leading cause of death globally and was responsible for 9.6 million deaths in 2018, according to The World Health Organization (WHO). Sarah Cannon, the Cancer Institute of HCA Healthcare, is honored to uphold the mission of World Cancer Day, which is marked on the fourth of February to increase awareness of cancer, to foster its prevention, early detection and treatment. This year marks the launch of the “I am and I will” campaign.

Standing together in solidarity with our cancer arm, We Are HCA Healthcare, We Are Sarah Cannon and We Will fight cancer together to make a positive impact on patients and communities everywhere.

A group of nurses and cancer patient holding signs for World Cancer Day

Cancer care team at Presbyterian/St. Luke’s Medical Center

A group of hospital caregivers

Pediatric hematology/oncology team at The Children’s Hospital at TriStar Centennial

Take a look at some of the ways we have committed to this cause, not just today, but every day for more than 25 years:


  • Sarah Cannon has been a key clinical trial leader in the majority of approved cancer therapies over the last decade.
  • With a network that spans the United States and United Kingdom, Sarah Cannon has hundreds of physicians who engage in research across its strategic sites, demonstrating its scale in being able to bring cutting-edge therapies closer to home for thousands of patients.
  • Sarah Cannon offers a large menu of clinical trial options today, studying more than 200 unique agents in trial each year.
  • Sarah Cannon enrolls more than 3,000 patients per year on clinical trials across its network. Sarah Cannon continues to be the leader for the industry with delivering novel therapies, and participating in breakthroughs in research, such as the first personalized cancer vaccine developed through molecularly sequencing the patient’s tumor. Sarah Cannon plays a similar leadership role with the anti-body drug conjugates, cellular therapies, and targeted small molecules.
A group of nurses holding signs that say #WeAreWeWill and #WeAreSarah

Infusion team at Henrico Doctors’ Hospital

A nurse and cancer patient holding signs for World Cancer Day

Presbyterian/St. Luke’s Medical Center


  • Sarah Cannon performs close to 1,200 hematopoietic stem cell transplants (blood and marrow transplants) per year – one of the leading providers in the world.
  • Sarah Cannon is one of the largest providers of radiation oncology services in the U.S.
  • Sarah Cannon has more than 200 oncology-trained nurse navigators helping patients though every aspect of the cancer journey.
  • Together, we serve more than 120,000 newly diagnosed patients annually.

About HCA Healthcare

HCA Healthcare, one of the nation's leading providers of healthcare services, is comprised of 183 hospitals and more than 2,300 sites of care, in 20 states and the United Kingdom. Our more than 283,000 colleagues are connected by a single purpose — to give patients healthier tomorrows.

As an enterprise, we recognize the significant responsibility we have as a leading healthcare provider within each of the communities we serve, as well as the opportunity we have to improve the lives of the patients for whom we are entrusted to care. Through the compassion, knowledge and skill of our caregivers, and our ability to leverage our scale and innovative capabilities, HCA Healthcare is in a unique position to play a leading role in the transformation of care.

Recent articles